Abstract LB207: Multi-ancestry genome- and transcriptome-wide association studies expand the susceptibility landscape for breast cancer overall and across subtypes

Abstract Breast cancer genomic studies have been conducted primarily in European-ancestry populations, limiting both diversity and statistical power. In this study, we substantially increased the representation of African- and Asian-ancestry women and markedly expanded the sample size of European descendants, creating the largest multi-ancestry dataset for breast cancer genome-wide association studies (GWAS) to date. With 237,817 cases and 1,679,059 controls, we conducted GWAS and transcriptome-wide association studies (TWAS) across ancestries and identified 326 risk loci and 113 genes associated with overall breast cancer risk at a P < 5 × 10⁻⁸ (for GWAS) and Bonferroni-corrected P of 1.54 × 10⁻⁴ (for TWAS), respectively. Of them, 153 risk loci and 69 genes were not reported previously. Subtype-specific analyses for estrogen receptor (ER) positive, ER-negative and triple-negative breast cancer (TNBC) revealed an additional 89 loci and 64 genes associated with breast cancer risk, including 61 loci and 12 genes not previously reported. Moreover, associations for 25 loci and 11 genes differed significantly by ER status, and 22 loci and eight genes were exclusively associated with risk of triple-negative breast cancer. Risk genes identified in this study were significantly enriched in pathways related to transcriptional regulation, estrogen response, mitotic spindle processes, and DNA damage repair. Together, these findings substantially expand the landscape of breast cancer susceptibility, subtype-specific genetic architecture, and provide added insights into breast cancer biology and genetics. Citation Format: Zheng Guo, Guochong Jia, Jie Ping, Xingyi Guo, Shuai Xu, Yulu Zheng, Thomas U. Ahearn, Christine Ambrosone, Montserrat Garcia-Closas, Jian Gu, Christopher A. Haiman, Dezheng Hu, Motoki Iwasaki, Sun-Young Kong, Sun-Seog Kweon, Koichi Matsuda, Keitaro Matsuo, Katherine L. Nathanson, Barbara Nemesure, Katie M. O'Brien, Olufunmilayo Olopade, Tuya Pal, Julie Palmer, Sue K. Park, Michael F. Press, Melissa Troester, Song Yao, Bingshan Li, Ran Tao, Xiao-Ou Shu, Jirong Long, Wei Zheng. Multi-ancestry genome- and transcriptome-wide association studies expand the susceptibility landscape for breast cancer overall and across subtypes [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 2 (Late-Breaking, Clinical Trial, and Invited Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(8_Suppl):Abstract nr LB207.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-17
DOI
https://doi.org/10.1158/1538-7445.am2026-lb207
Primary Topic
Genetic Associations and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract LB207: Multi-ancestry genome- and transcriptome-wide association studies expand the susceptibility landscape for breast cancer overall and across subtypes

Sue K. ParK, Guochong Jia, Thomas U. Ahearn, B Nemesure et al.
Cancer Research
Genetic Associations and Epidemiology
article

Abstract LB207: Multi-ancestry genome- and transcriptome-wide association studies expand the susceptibility landscape for breast cancer overall and across subtypes

Sue K. ParK, Guochong Jia, Thomas U. Ahearn, B Nemesure, Yulu Zheng, Michael F. Press, Koichi Matsuda, Zheng Guo, OI Olopade, Julie Palmer, Christine Ambrosone, Ran Tao, Jian Gu, Montserrat Garcia-Closas, Tuya Pal, Dezheng Hu, Motoki Iwasaki, Jie Ping, Song Yao, Katherine L. Nathanson, Xiao-Ou Shu, Sun-Young Kong, Wei Zheng, Keitaro Matsuo, Shuai Xu, Katie M. O'Brien, Jirong Long, Sun-Seog Kweon, Xingyi Guo, Bingshan Li, Christopher A. Haiman, Melissa Troester
article en

Abstract

Abstract Breast cancer genomic studies have been conducted primarily in European-ancestry populations, limiting both diversity and statistical power. In this study, we substantially increased the representation of African- and Asian-ancestry women and markedly expanded the sample size of European descendants, creating the largest multi-ancestry dataset for breast cancer genome-wide association studies (GWAS) to date. With 237,817 cases and 1,679,059 controls, we conducted GWAS and transcriptome-wide association studies (TWAS) across ancestries and identified 326 risk loci and 113 genes associated with overall breast cancer risk at a P < 5 × 10⁻⁸ (for GWAS) and Bonferroni-corrected P of 1.54 × 10⁻⁴ (for TWAS), respectively. Of them, 153 risk loci and 69 genes were not reported previously. Subtype-specific analyses for estrogen receptor (ER) positive, ER-negative and triple-negative breast cancer (TNBC) revealed an additional 89 loci and 64 genes associated with breast cancer risk, including 61 loci and 12 genes not previously reported. Moreover, associations for 25 loci and 11 genes differed significantly by ER status, and 22 loci and eight genes were exclusively associated with risk of triple-negative breast cancer. Risk genes identified in this study were significantly enriched in pathways related to transcriptional regulation, estrogen response, mitotic spindle processes, and DNA damage repair. Together, these findings substantially expand the landscape of breast cancer susceptibility, subtype-specific genetic architecture, and provide added insights into breast cancer biology and genetics. Citation Format: Zheng Guo, Guochong Jia, Jie Ping, Xingyi Guo, Shuai Xu, Yulu Zheng, Thomas U. Ahearn, Christine Ambrosone, Montserrat Garcia-Closas, Jian Gu, Christopher A. Haiman, Dezheng Hu, Motoki Iwasaki, Sun-Young Kong, Sun-Seog Kweon, Koichi Matsuda, Keitaro Matsuo, Katherine L. Nathanson, Barbara Nemesure, Katie M. O'Brien, Olufunmilayo Olopade, Tuya Pal, Julie Palmer, Sue K. Park, Michael F. Press, Melissa Troester, Song Yao, Bingshan Li, Ran Tao, Xiao-Ou Shu, Jirong Long, Wei Zheng. Multi-ancestry genome- and transcriptome-wide association studies expand the susceptibility landscape for breast cancer overall and across subtypes [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 2 (Late-Breaking, Clinical Trial, and Invited Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(8_Suppl):Abstract nr LB207.

Cancer ResearchVol. 86(8_Supplement)
Boston University (US), University of North Carolina at Chapel Hill (US), Roswell Park Comprehensive Cancer Center (US), The University of Texas MD Anderson Cancer Center (US), Tokyo Medical University (JP), Vanderbilt University (US), Keck Hospital of USC (US), New Generation University College (ET), Edinburgh Cancer Research (GB), University of Massachusetts Boston (US), University of Chicago (US), National Cancer Center (US), National Institute of Environmental Health Sciences (US), USC Norris Comprehensive Cancer Center (US), Aichi Cancer Center (JP), The Cancer Institute Hospital (JP), Chonnam National University Hwasun Hospital (KR), National Cancer Research Institute (GB), Stony Brook University (US), University of Pennsylvania (US), Vanderbilt University Medical Center (US)
Gender equality
Openalex Percentile: Top 19%
Genetic Associations and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.